162 results
Page 2 of 9
6-K
EX-99.1
z2xigxr
2 Nov 22
Mereo BioPharma Received Notification of Nasdaq Minimum Bid Price Deficiency
4:07pm
6-K
EX-99.2
bvh2l561 d9fvef6
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.1
ny04cn2a
28 Oct 22
Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management
7:11am
6-K
EX-99.1
q1zpmid986 p2ifk0dme
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
6-K
EX-99.1
6hc9v02mcd98u8vdgj
18 Oct 22
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
7:07am
6-K
EX-99.1
vvie9hjeu gf10
17 Oct 22
Mereo BioPharma Receives FDA Fast Track Designation for Alvelestat for Treatment of
7:16am
6-K
EX-99.1
k4emtjiw0 pomb5li
3 Oct 22
Mereo BioPharma Confirms Receipt of a Valid Notice Requiring it to Convene a General Meeting of Shareholders
5:43pm
6-K
EX-99.1
4eq ebp14dqgd5iwd7
26 Sep 22
Mereo BioPharma Offered to Settle Proxy Contest with Rubric Capital Management by
7:18am
6-K
EX-99.1
qf0qbu8z7j5ljpwem
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
n7sr3gh26jicr
22 Aug 22
Notifies Rubric of Certain Deficiencies in its Notice Purporting to Call a General Meeting of Shareholders
4:06pm
6-K
EX-99.1
pa3xcm1
5 Jul 22
Current report (foreign)
4:15pm
6-K
EX-99.1
i3z20xtrn 5q2c
2 Jun 22
Mereo Also Updates Capital Allocation and Portfolio Prioritization Plan
9:07am
6-K
EX-99.1
vjwf91m1iz2mp
26 May 22
Current report (foreign)
5:11pm
6-K
EX-99.1
we6e6gxg hqv8cbha
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
goxiiwgvj9il pr5icaz
9 May 22
Current report (foreign)
8:15am
6-K
EX-99.1
3qtr4
9 May 22
Current report (foreign)
8:06am
6-K
j0lulicok lm
9 May 22
Current report (foreign)
8:06am